SCHEMBL5055359

SCHEMBL5055359

CCCC1CC(=O)N(Cn2nnc3ccccc32)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 7/20 0.48
CYP2D6 P10635 1/20 0.42
HCRTR1 O43613 1/20 0.40
HCRTR2 O43614 1/20 0.40
GLA P06280 1/20 0.39
TSHR P16473 1/20 0.39
APAF1 O14727 1/20 0.39
POLB P06746 1/20 0.39
GRM2 Q14416 1/20 0.39
ALDH1A1 P00352 1/20 0.39
EGLN3 Q9H6Z9 1/20 0.39
GAA P10253 5/20 0.38
MGAM O43451 4/20 0.38
AMY1A P0DUB6 4/20 0.38
SI P14410 4/20 0.38
MGAM2 Q2M2H8 4/20 0.38
RAB9A P51151 3/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL661637 0.79 HTT (0.45) TSHRAPAF1EGLN3SMN1; SMN2
SCHEMBL662964 0.78 ALDH1A1 (0.43) TSHRPOLBALDH1A1RAB9ANPC1
SCHEMBL17938022 0.78 ALDH1A1 (0.32) TSHRPOLBALDH1A1
SCHEMBL13238348 0.78 ALDH1A1 (0.41) TSHRPOLBALDH1A1RAB9ANPC1
SCHEMBL662479 0.77 POLB (0.50) CYP2D6TSHRPOLBALDH1A1
SCHEMBL1665637 0.77 LMNA (0.42) TSHRPOLBALDH1A1SMN1; SMN2
SCHEMBL662975 0.76 LMNA (0.48) GLATSHRALDH1A1GAASMN1; SMN2
SCHEMBL2954372 0.75 RXRA (0.48) TSHRPOLBALDH1A1GAA
SCHEMBL2954874 0.75 KDM4E (0.45) TSHRPOLBALDH1A1GAA
SCHEMBL663077 0.75 LMNA (0.44) TSHRPOLBALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912966-A2 2-OXO-1-PYRROLIDINE DERIVATIVES AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB, S.A. (BE) 2008-04-23 EP claimed
WO-2006128692-A2 2-OXO-1-PYRROLIDINE DERIVATIVES AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB PHARMA, S.A. (BE) 2006-12-07 WO claimed
EP-1912966-A2 2-OXO-1-PYRROLIDINE DERIVATIVES AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB, S.A. (BE) 2008-04-23 EP disclosed
EP-1891042-A2 2-OXO-1-PYRROLIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB Pharma, S.A. (BE) 2008-02-27 EP disclosed
WO-2006128692-A2 2-OXO-1-PYRROLIDINE DERIVATIVES AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB PHARMA, S.A. (BE) 2006-12-07 WO disclosed
WO-2006128693-A2 2 -OXO-I -PYRROLIDINE DERIVATIVES/ PROCESSES FOR PREPARING THEM AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB PHARMA, S.A. (BE) 2006-12-07 WO disclosed